Da Nang hospital, UK firm cooperate in lung cancer treatment capacity building
Da Nang Oncology Hospital and the UK's AstraZeneca Vietnam on March 12 signed an agreement to improve treatment capacity and the quality of medical care for lung cancer patients, targeting those in central Vietnam.
An agreement is signed between Da Nang Oncology Hospital and AstraZeneca Vietnam to improve treatment capacity and the quality of medical care for lung cancer patients in central Vietnam. (Photo: VNA)
Da Nang (VNA) – Da Nang Oncology Hospital and the UK's AstraZeneca Vietnam on March 12 signed an agreement to improve treatmentcapacity and the quality of medical care for lung cancer patients, targeting those in centralVietnam.
Under the agreement, the two sides will cooperate in conductingclinical studies of cancer, developing and implementing programmes in trainingfor medical workers and patients’ support delivery; and promoting internationalcooperation in oncology.
Director of the Da Nang Oncology Hospital Tran Tu Quy saidthe deal will help comprehensively enhance capacity in cancer screening andtreatment and benefit patients in not only Da Nang but also surrounding areas.
On this occasion, the two sides partnered in the programme “VietnamHealthy Lung” between 2021 – 2023, aimed at raising the quality of respiratorydisease management in Vietnam. The programme has entered the second phase withexpansion into the field of lung cancer.
It is estimated that over 4.2 percent of Vietnam’s populationsuffers from Chronic Obstructive Pulmonary Disease. It is worrying that most ofthem are not currently diagnosed due to a lack of medical facilities, poorawareness of patients and limitations in the professional skills of publichealth, according to the health ministry.
Vietnam each year reported about 23,667 new lung cancercases and 20,170 deaths. Most people with cancer in Vietnam visit hospitals formedical examination and treatment in a late stage, making treatment difficultand creating a huge financial burden on patients./.
The number of lung cancer patients in Indonesia has increased nearly 10-fold compared to 15 years ago, data from the Indonesian Lung Association (PDPI) showed.
Cancer is the second leading cause of death in Vietnam, accounting for 17.9 percent and 19.9 percent of total deaths caused by diseases in the country in 2010 and 2017, respectively.
Vietnamese patients with respiratory problems, especially lung cancer, will benefit from the second phase of the "Vietnam Healthy Lung" programme in 2021-23 that was signed between the health ministry’s Medical Services Administration (MSA) and AstraZeneca on November 16.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
An agreement is signed between Da Nang Oncology Hospital and AstraZeneca Vietnam to improve treatment capacity and the quality of medical care for lung cancer patients in central Vietnam. (Photo: VNA)
